Rib-X Pharmaceuticals to Present 16 Posters Highlighting Data from its Antibiotic Development Programs at ICAAC – Phramalive.com

is a novel hospital-focused fluoroquinolone antibiotic candidate with excellent demonstrated activity against a variety of quinolone-resistant Gram-positive and Gram-negative bacteria, including quinolone-resistant MRSA. The delafloxacin poster will be …